Press "Enter" to skip to content

It sector Q4Fy25 Review: After a MUUUTED SHOW, Can Investors Expect a Turnaround in Next Quarter?

“” The Earnings Season for the Quarter Ending March 31, 2025, Began with Leading It Firms Releasing their Financial Results in the first week of april and concluded in the final week of May 2025.

WhatsApp Group Join Now
Telegram Group Join Now

In Q4FY25, Major Indian It Services Company Saw a Quarter-On -Quarter Decline in Revenue-Marking The First Time This Has Happy Since Since Q1fy21, Whhen Performance was affected by the covid-19 outbreak

According to analysts, the slowdown was primarily caused by delays in project ramp-ups, weak performance in certain Industry segments, and Reduced Deming Stming Steming from the ongoing TARIFGING TARIFGINGS

Brokerage firm choice broking said in a note that tier-l iterrs have lowered their fy26e revidance band by 1%, with the lower end factoring in constructed Demand Weekness and the Midpoint Association Closure of Key Large Deals Under Current Macro Conditions, In Response to the Uncertain Environment.

“We expect it services companies to post modest growth in fy26e, Constrained by cautious client spending and a challenging demand environment. 4.0%, while mid-tier firms are likely to outperform with 5%to 28%, “said the brokege firm.

Nifty it performance during Q4 FY25

The nifty it index has surpassed the broader market’s performance by 2.2% in the past month, fuled by renewed optimism stemming from the us-china trade deal.

“We Remain Constructive on Firms with Diversified Portfolios Catering to Both Costs Take and Discretion Execution strength.

Disclaimer: This story is for educational purposes only. The views and recommendations about individual analysts or broking companies, not mint. We Advise Investors to Check With Certified Experts Before Making Any Investments Decisions.

Source link


Discover more from Gautam Kalal

Subscribe to get the latest posts sent to your email.

More from FinanceMore posts in Finance »

Be First to Comment

Leave a Reply